Osteoarthritis of the first carpometacarpal joint. Osteoarthritis of first carpometacarpal joint, unspecified
Conditions
Interventions
Intervention 1: Intervention group 1 (Carpometacarpal joint injection under ultrasound guide): In this group, after diagnosis, patients will be treated with corticosteroid injection into the 1st CMC j
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age at least 18 years old History of pain of first CMC joint during rest or activity that has last for at least 3 months Have VAS score at least 3 before entering the study Pain during touch of the dorsal surface of the CMC OA radiographic evidence of reduced articular space or osteophyte formation (grade 2,3) No response to common osteoarthritis treatments including oral and topical skin treatments, physiotherapy, exercise therapy, contrast bath
Exclusion criteria
Exclusion criteria: No patient access for post-intervention investigation due to no personal referral Patient's willing to use systemic steroids or intra-articular injection other than injectable drugs under the study Radiographic evidence of severe osteoarthritis (grade 4) Previous history of first carpometacarpal surgery History of any intra-CMC1 joint injection in the past six months Use of physiotherapy modality during the last 3 months Presence of steroid / lidocain injection contraindication such as sensitivity to these drugs and infection at the site of injection presence of a risk factor for intra-articular injection such as anti-coagulation use Poor control of diabetes, coagulation diseases, fractures, rheumatologic diseases, tumors, infections, gout, pregnancy or decision to get pregnant Severe deformity of the joint Acute trauma (last 3 months)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain severity. Timepoint: At baseline and 2, 6, and 12 weeks after injection. Method of measurement: Visual Analogue Scale (VAS).;Hand functional ability. Timepoint: At baseline and 2, 6, and 12 weeks after injection. Method of measurement: FIHOA questionnaire.;Upper limb disability. Timepoint: At baseline and 2, 6, and 12 weeks after injection. Method of measurement: Quick-DASH Questionnaire.;Pinch power which is the power of thumb to squeeze something. Timepoint: At baseline and 2, 6, and 12 weeks after injection. Method of measurement: Dynamometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Hosseini
Tehran University of Medical Sciences
Outcome results
None listed